<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01938040</url>
  </required_header>
  <id_info>
    <org_study_id>2012001793</org_study_id>
    <nct_id>NCT01938040</nct_id>
  </id_info>
  <brief_title>Effect IV Ibuprofen and Inflammatory Responses</brief_title>
  <official_title>Randomized, Double Blind, Pilot Study on the Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia: Correlation With Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Medicine and Dentistry of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rutgers, The State University of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done because the investigators wish to study ways to improve recovery
      after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the
      body's attempt to protect itself and to start the healing process. Some surgical
      complications are related to the body's natural inflammatory response. Although mainly a
      healing response, inflammation can also have side effects which delay recovery. The
      investigators wish to determine the effect of a medication known as ibuprofen on recovery.
      You may know ibuprofen by the name Advil or Motrin. The medication will be given through the
      vein prior to the start of the surgery. Three blood samples will be taken, two while the
      patient is under anesthesia. The subject will be asked to complete several questionnaires.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, placebo-controlled, two-arm parallel, multi-center study.

      Thirty subjects (15 in each arm) will be enrolled. Subjects, over the age of 18, undergoing
      laparoscopic cholecystectomy under general anesthesia will be screened for eligibility to
      participate in the study. Subjects will be screened, recruited, and randomized during the
      preadmission visit or the day of surgery. Eligible subjects will be randomized to one of the
      two treatment group in a 1:1 ratio to receive either IV ibuprofen or matching placebo. Both
      men and women will be recruited, and there is no limitation as to racial and ethnic origin.

      Participation in the study will not alter the patient's anesthetic management. Routine
      anesthesia monitors used during general anesthesia will be used. Patients will receive either
      800mg IV ibuprofen or placebo pre-operatively. After pre-oxygenation, general anesthesia will
      be induced with lidocaine (1 mg/kg), propofol (1-2 mg/kg), and fentanyl (up to 5 mcg/kg).
      Tracheal intubation will be facilitated with rocuronium (0.6 mg/kg). Anesthesia will be
      maintained with air/oxygen (60%/40%), sevoflurane, and fentanyl. The anesthesiologist will be
      allowed to administer additional doses of fentanyl at his/her discretion. All patients will
      receive ondansetron 4 mg prior to the end of operation. Patients will be awakened and
      extubated in the OR and will be transferred to the Post Anesthesia Care Unit (PACU) after
      following simple commands. All patients will also be able to receive rescue doses of opioids
      as indicated by a Numeric Pain Rating Scale score &gt;2 or upon request.

      ii. Sample Size Justification: The proposed study is a pilot trial designed to explore the
      relationship between inflammatory markers and the quality of recovery. To our knowledge this
      vital connection has never been investigated. Therefore, we cannot use commonly accepted
      methods of sample size calculations. Mahdy et al examined levels of IL-6, IL-10, and cortisol
      in patients undergoing urological surgery and treated with indomethacin versus placebo (12).
      A sample size of twenty three patients per group was sufficient to show a difference in
      cytokine levels. Tasdogan et al compared levels of interleukin (IL)-1, IL-6, and tumor
      necrosis factor (TNF)-alpha in patients requiring postoperative ventilation after abdominal
      surgery and treated with dexmedetomidine versus propofol (18). A sample size of twenty
      patients per group was sufficient to demonstrate the difference in cytokine concentrations.
      Kim et al studied changes in cytokine levels in patients undergoing total abdominal
      hysterectomy and pretreated with clonidine (19). These investigators studied ten patients per
      group. The sample size was sufficient to demonstrate changes in IL-6 related to surgical
      stress. Therefore, we believe, that a sample size of 30 patients per group is an adequate
      sample to demonstrate the changes in level of inflammatory markers and explore the quality of
      recovery.

      iii. IV ibuprofen administration The study drug will be given via intravenous infusion
      beginning after a placement of the IV line. The dose will be fixed at 800mg infused over 5
      minutes.

      iv. Inclusion criteria:

        1. Adults, 18 and over, who will undergo laparoscopic cholecystectomy.

        2. Subject is non-lactating and is either:

             1. Not of childbearing potential

             2. Of childbearing potential but is not pregnant at time of baseline as determined by
                pre-surgical pregnancy testing.

        3. Subject is American Society of Anesthesiologists physical status 1, 2, or 3. v.
           Exclusion criteria:

      1. Cognitively impaired (by history) 2. Subject requires chronic antipsychotic history 3.
      Subject is anticipated to require an additional surgery within 90 days after the intended
      surgery 4. Chronic use of steroids or opioids 5. Subject has received treatment with COX
      inhibitors within 3 days of study entry 6. Subject for whom opiates, benzodiazepines, and COX
      inhibitors are contraindicated vi. Endpoints: Concentration of the cytokines TNF-alpha,
      IL-1Beta, IL-2, IL-6, IL-10, and IFN-gamma as well as prostaglandin E2, cortisol and c
      reactive protein at different time points will be our primary outcome. Changes in mediator
      levels in the IV ibuprofen versus placebo groups will be compared. Plasma samples will be
      collected before administration of any drug (after placement of IV lines), before induction,
      at the end of the surgery in the operating room and 2-3 hours after the end of the surgery in
      the PACU.

      All plasma samples will be analyzed in the laboratory of Susan Gould-Fogerite. The secondary
      outcome parameters will be the quality of recovery score (QoR-40) to measure quality of
      recovery from surgery and a simple fatigue scale. Forty questions in five dimensions will be
      scored by patients on a five-point Likert scale. This assessment was developed and validated
      by Myles et al (20). Nine points fatigue scale is often used to assess progress of recovery
      in head trauma patients. Geriatric depression scale and digits backward and forward will be
      utilized. All metrics will be administered on the day of surgery, before the surgery, 2-3
      hours after the end of the surgery in the PACUand on postoperative days 1 and 3. Exploratory
      analysis will examine whether correlations exist between inflammatory mediator concentrations
      and the objective measures of recovery and fatigue.

      vii. Methods and Procedures

      1. Data monitoring plan Adverse events will include events reported by the subject and
      thought to be associated with the research. Unanticipated problems and adverse events will be
      gathered by study investigators. Adverse events will be evaluated at each study visit,
      including follow up telephone calls. Any serious adverse effects will be reported to the
      Institutional Review Board (IRB) according to regulatory requirements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stress Response Inflammation Markers :Cortisol and C Reactive Protein (CRP)</measure>
    <time_frame>2 hours following end of surgery</time_frame>
    <description>Serum concentration of cortisol, CRP, drawn in Post Anesthesia Care unit at 2 hours following surgery were compared with those same levels drawn preoperatively and intraoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immune Response IL-6</measure>
    <time_frame>2 hours postoperatively in PACU</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery-40</measure>
    <time_frame>preoperatively and -postoperative days 1 and 3</time_frame>
    <description>Quality of Recovery-40 has been used to assess postoperative recovery from anesthesia where higher score correlate with improved recovery and well being. The survey has 5 domains: comfort scale ranges 1-60 with higher value indicating greater comfort, emotions scale ranges 1-45 with higher value indicating best emotional state, physical independence scale ranges 1-25 with higher value indicating best independence, patient support scale ranges 1-35 with a higher score indicating greater support and pain scale 1-35 with higher number indicating greater relief from pain. Scoring is done for PART A on a scale of 1-5 (1=very poor=none of the time, worst score, 5=excellent=all of the time, best possible score).PART B on a scale of 1-5 (1=very poor or all the time worse score), 5=excellent or none of the time, best score) Perfect score=200.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Fatigue Severity Scale</measure>
    <time_frame>preoperative-postoperative day 1 and day 3</time_frame>
    <description>This questionnaire contains 9 statements that rate severity of fatigue symptoms. Score 1 indicates strong disagreement with the statement and 7= strong agreement. i.e (I am easily fatigued).Total lowest possible score indicating no fatigue is 9. Total highest possible score is 63 which correlates to severe fatigue, interfering with all activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immune Response:Serum Concentration of IL-10,</measure>
    <time_frame>2 hours post arrival in PACU</time_frame>
    <description>.drawn in PACU 2 hours following arrival and compared to preoperative and intraoperative values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Recovery.</measure>
    <time_frame>preoperatively- 2 hours in PACU, Post op day #1, post op day#3</time_frame>
    <description>Digits span forward subject is asked to repeat a series of numbers with increasing number of digits forward. Digit span backward subject is asked to repeat a series of numbers backward with increasing number of digits. Correct response is worth 1 point. Maximum of 14 points for each sub score with a total of 28 points for total score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric Depression Scale</measure>
    <time_frame>Preoperatively, post operative day 1 and post op day3</time_frame>
    <description>15 questions. Score 1 point for each answer selected which indicates depression. Score of 0-5 is normal. A score &gt;5 suggests depression.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cytokine Concentrations</measure>
    <time_frame>preoperative-intraoperative-postopoperative</time_frame>
    <description>IFN y, IL-1B IL-2 were below the limit of detection and no assessments could be made. The lower limit for all cytokine detection was 3.2pg/mL</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Gallbladder Disease</condition>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>800mg administered IV in 100cc of normal saline over 5 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100mL of normal saline to be administered over 5 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ibuprofen</intervention_name>
    <description>single preoperative dose prior to surgery</description>
    <arm_group_label>Ibuprofen</arm_group_label>
    <other_name>caldolor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sugar water/placebo</intervention_name>
    <description>single preoperative dose prior to surgery</description>
    <arm_group_label>Sugar water</arm_group_label>
    <other_name>100mL. intravenous sugar water administered over 5 minutes</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing laparoscopic cholecystectomy under general anesthesia

          -  American Society of Anesthesiologists status of 1, 2 or 3 (as determined by the
             anesthesiologists)

          -  not pregnant of breast feeding

        Exclusion Criteria:

          -  cognitively impaired

          -  using antipsychotic drugs

          -  chronic use of steroids or opioids

          -  subject has received COX inhibitors within 3 days if surgery

          -  subjects for whom opiates, benzodiazepines and COX inhibitors are contraindicated

          -  subjects with a history of bleeding disorders or peptic ulcer disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alex Bekker, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rutgers/NJMS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MT. Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Le V, Kurnutala L, SchianodiCola J, Ahmed K, Yarmush J, Daniel Eloy J, Shapiro M, Haile M, Bekker A. Premedication with Intravenous Ibuprofen Improves Recovery Characteristics and Stress Response in Adults Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled Trial. Pain Med. 2016 Feb 18. pii: pnv113. [Epub ahead of print]</citation>
    <PMID>26893119</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2013</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2013</study_first_posted>
  <results_first_submitted>September 23, 2015</results_first_submitted>
  <results_first_submitted_qc>October 28, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2016</results_first_posted>
  <last_update_submitted>October 28, 2016</last_update_submitted>
  <last_update_submitted_qc>October 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laparoscopic cholecystectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>60 patients were recruited from the Same Day Surgery Unit at three hospital locations. The dates of recruitment were from 12/1/2011 to 10/2/13.</recruitment_details>
      <pre_assignment_details>Of the 60 patients randomized 5 did not receive study medication. The surgical case was either cancelled or the subjects withdrew consent.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Caldolor/Ibuprofen</title>
          <description>800mg administered IV in 100mL normal saline over 5 minutes prior to surgical incision.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Plasma Analysis</title>
              <participants_list>
                <participants group_id="P1" count="24">complete set of blood samples could not be obtained</participants>
                <participants group_id="P2" count="25">complete set of blood samples could not be obtained</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Behavior Metrics</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Ibuprofen/Caldolor</title>
          <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="55"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <description>All subjects were from the Northeast section of the United States and all were English speaking. The behavioral questionnaires were copyrighted and validated in English only.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Stress Response Inflammation Markers :Cortisol and C Reactive Protein (CRP)</title>
        <description>Serum concentration of cortisol, CRP, drawn in Post Anesthesia Care unit at 2 hours following surgery were compared with those same levels drawn preoperatively and intraoperatively.</description>
        <time_frame>2 hours following end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Stress Response Inflammation Markers :Cortisol and C Reactive Protein (CRP)</title>
          <description>Serum concentration of cortisol, CRP, drawn in Post Anesthesia Care unit at 2 hours following surgery were compared with those same levels drawn preoperatively and intraoperatively.</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>cortisol-PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173.6" spread="29.5"/>
                    <measurement group_id="O2" value="289.5" spread="25.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CRP-PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" spread="1"/>
                    <measurement group_id="O2" value="17" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Sympathetic Response: Epinephrine and Norepinephrine Plasma Concentrations</title>
        <time_frame>intraoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Sympathetic Response: Epinephrine and Norepinephrine Plasma Concentrations</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Epinephrine Intraoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="0.03"/>
                    <measurement group_id="O2" value="0.23" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norepinephrine Intraoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.52" spread="0.09"/>
                    <measurement group_id="O2" value="1.06" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Immune Response: TNF Alpha</title>
        <time_frame>preoperatively-intraoperatively-postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Immune Response: TNF Alpha</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>TNF a Preop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.1" lower_limit="2.9" upper_limit="31.2"/>
                    <measurement group_id="O2" value="11.3" lower_limit="2.9" upper_limit="28.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TNFa Intraop</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14" lower_limit="4.5" upper_limit="76.7"/>
                    <measurement group_id="O2" value="8.9" lower_limit="2.8" upper_limit="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TNF a post op</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.8" lower_limit="3.6" upper_limit="43.1"/>
                    <measurement group_id="O2" value="10.6" lower_limit="3.6" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>IL-6</title>
        <time_frame>preoperatively-intraoperatively-postoperatively</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>IL-6</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-6 preoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" lower_limit="0.3" upper_limit="22.2"/>
                    <measurement group_id="O2" value="1.2" lower_limit="0.4" upper_limit="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 intraoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.4" upper_limit="56.4"/>
                    <measurement group_id="O2" value="1.1" lower_limit="0.3" upper_limit="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 postoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.9" upper_limit="80.4"/>
                    <measurement group_id="O2" value="7.7" lower_limit="0.5" upper_limit="59.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Immune Response IL-6</title>
        <time_frame>2 hours postoperatively in PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Immune Response IL-6</title>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-6 PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.9" upper_limit="80.4"/>
                    <measurement group_id="O2" value="7.7" lower_limit="0.5" upper_limit="59.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 preoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" lower_limit="0.3" upper_limit="22.2"/>
                    <measurement group_id="O2" value="1.2" lower_limit="0.4" upper_limit="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-6 intraoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" lower_limit="0.4" upper_limit="56.4"/>
                    <measurement group_id="O2" value="1.1" lower_limit="0.3" upper_limit="22.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery-40</title>
        <description>Quality of Recovery-40 has been used to assess postoperative recovery from anesthesia where higher score correlate with improved recovery and well being. The survey has 5 domains: comfort scale ranges 1-60 with higher value indicating greater comfort, emotions scale ranges 1-45 with higher value indicating best emotional state, physical independence scale ranges 1-25 with higher value indicating best independence, patient support scale ranges 1-35 with a higher score indicating greater support and pain scale 1-35 with higher number indicating greater relief from pain. Scoring is done for PART A on a scale of 1-5 (1=very poor=none of the time, worst score, 5=excellent=all of the time, best possible score).PART B on a scale of 1-5 (1=very poor or all the time worse score), 5=excellent or none of the time, best score) Perfect score=200.</description>
        <time_frame>preoperatively and -postoperative days 1 and 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery-40</title>
          <description>Quality of Recovery-40 has been used to assess postoperative recovery from anesthesia where higher score correlate with improved recovery and well being. The survey has 5 domains: comfort scale ranges 1-60 with higher value indicating greater comfort, emotions scale ranges 1-45 with higher value indicating best emotional state, physical independence scale ranges 1-25 with higher value indicating best independence, patient support scale ranges 1-35 with a higher score indicating greater support and pain scale 1-35 with higher number indicating greater relief from pain. Scoring is done for PART A on a scale of 1-5 (1=very poor=none of the time, worst score, 5=excellent=all of the time, best possible score).PART B on a scale of 1-5 (1=very poor or all the time worse score), 5=excellent or none of the time, best score) Perfect score=200.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preop comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.5" spread="5.69"/>
                    <measurement group_id="O2" value="56.8" spread="5.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preop emotion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.9" spread="3.7"/>
                    <measurement group_id="O2" value="43" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preop phy indep</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.8" spread="0.7"/>
                    <measurement group_id="O2" value="24.6" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>preop support</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9" spread="0.19"/>
                    <measurement group_id="O2" value="34.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>preop pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" spread="1.3"/>
                    <measurement group_id="O2" value="33.7" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD #1 comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58." spread="2.72"/>
                    <measurement group_id="O2" value="51.2" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD #1 emotion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.4" spread="1.3"/>
                    <measurement group_id="O2" value="40.4" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD #1phy ind</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.8" spread="5.7"/>
                    <measurement group_id="O2" value="23.5" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD #1 support</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.6" spread="5.7"/>
                    <measurement group_id="O2" value="34.2" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD# 1 pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.6" spread="1.8"/>
                    <measurement group_id="O2" value="27" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD#3 comfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.4" spread="0.9"/>
                    <measurement group_id="O2" value="55" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD #3 emotion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.8" spread="0.6"/>
                    <measurement group_id="O2" value="43" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD#3 phy ind</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.7" spread="0.8"/>
                    <measurement group_id="O2" value="24" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD#3 support</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.8" spread="0.9"/>
                    <measurement group_id="O2" value="33.6" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>POD#3 pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" spread="0.75"/>
                    <measurement group_id="O2" value="30.4" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Modified Fatigue Severity Scale</title>
        <description>This questionnaire contains 9 statements that rate severity of fatigue symptoms. Score 1 indicates strong disagreement with the statement and 7= strong agreement. i.e (I am easily fatigued).Total lowest possible score indicating no fatigue is 9. Total highest possible score is 63 which correlates to severe fatigue, interfering with all activities of daily living.</description>
        <time_frame>preoperative-postoperative day 1 and day 3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen/Caldolor</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Modified Fatigue Severity Scale</title>
          <description>This questionnaire contains 9 statements that rate severity of fatigue symptoms. Score 1 indicates strong disagreement with the statement and 7= strong agreement. i.e (I am easily fatigued).Total lowest possible score indicating no fatigue is 9. Total highest possible score is 63 which correlates to severe fatigue, interfering with all activities of daily living.</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" spread="8.87"/>
                    <measurement group_id="O2" value="16.5" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.6" spread="11"/>
                    <measurement group_id="O2" value="26.9" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" spread="9.9"/>
                    <measurement group_id="O2" value="25" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op day #3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.1" spread="6.57"/>
                    <measurement group_id="O2" value="20.8" spread="8.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Immune Response:Serum Concentration of IL-10,</title>
        <description>.drawn in PACU 2 hours following arrival and compared to preoperative and intraoperative values</description>
        <time_frame>2 hours post arrival in PACU</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ibuprofen</title>
            <description>800mg administered IV in 100cc of normal saline over 5 minutes
ibuprofen: single preoperative dose prior to surgery</description>
          </group>
          <group group_id="O2">
            <title>Sugar Water</title>
            <description>100mL of normal saline to be administered over 5 minutes
sugar water/placebo: single preoperative dose prior to surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Immune Response:Serum Concentration of IL-10,</title>
          <description>.drawn in PACU 2 hours following arrival and compared to preoperative and intraoperative values</description>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>IL-10 PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="0.1" upper_limit="32.2"/>
                    <measurement group_id="O2" value="21.8" lower_limit="0.1" upper_limit="113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10 preoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.0" upper_limit="11.2"/>
                    <measurement group_id="O2" value="1.3" lower_limit="0.23" upper_limit="24.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IL-10 intraoperatively</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" lower_limit="0.3" upper_limit="76.3"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.6" upper_limit="26.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Cytokine Concentrations</title>
        <description>IFN y, IL-1B IL-2 were below the limit of detection and no assessments could be made. The lower limit for all cytokine detection was 3.2pg/mL</description>
        <time_frame>preoperative-intraoperative-postopoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>800 mg in 100mL of normal saline over 5 minutes</description>
          </group>
        </group_list>
        <measure>
          <title>Cytokine Concentrations</title>
          <description>IFN y, IL-1B IL-2 were below the limit of detection and no assessments could be made. The lower limit for all cytokine detection was 3.2pg/mL</description>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognitive Recovery.</title>
        <description>Digits span forward subject is asked to repeat a series of numbers with increasing number of digits forward. Digit span backward subject is asked to repeat a series of numbers backward with increasing number of digits. Correct response is worth 1 point. Maximum of 14 points for each sub score with a total of 28 points for total score</description>
        <time_frame>preoperatively- 2 hours in PACU, Post op day #1, post op day#3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caldolor/Ibuprofen</title>
            <description>800mg administered IV in 100mL normal saline over 5 minutes prior to surgical incision.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Cognitive Recovery.</title>
          <description>Digits span forward subject is asked to repeat a series of numbers with increasing number of digits forward. Digit span backward subject is asked to repeat a series of numbers backward with increasing number of digits. Correct response is worth 1 point. Maximum of 14 points for each sub score with a total of 28 points for total score</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preop forward total</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="1.9"/>
                    <measurement group_id="O2" value="8.9" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>preoperative forward max len</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="0.89"/>
                    <measurement group_id="O2" value="7.08" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre op backward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="2.08"/>
                    <measurement group_id="O2" value="7.7" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preop backward max len</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="1.1"/>
                    <measurement group_id="O2" value="5.5" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU forward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" spread="2.6"/>
                    <measurement group_id="O2" value="4.4" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU for max length</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="1.7"/>
                    <measurement group_id="O2" value="4.4" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU backward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="2.9"/>
                    <measurement group_id="O2" value="3.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU back max length</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="1.7"/>
                    <measurement group_id="O2" value="3.0" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op #1forward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="1.6"/>
                    <measurement group_id="O2" value="8.8" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op day 1max length</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.03" spread="0.89"/>
                    <measurement group_id="O2" value="7.6" spread="0.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op #1backward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" spread="1.6"/>
                    <measurement group_id="O2" value="7.8" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op day #1max length</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="0.8"/>
                    <measurement group_id="O2" value="5.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post op #3 forward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="1.5"/>
                    <measurement group_id="O2" value="8.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post #3 for max length</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="0.89"/>
                    <measurement group_id="O2" value="6.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day #3backward tot</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="1.8"/>
                    <measurement group_id="O2" value="7.6" spread="1.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op #3 max length</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.03" spread="1.09"/>
                    <measurement group_id="O2" value="5.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geriatric Depression Scale</title>
        <description>15 questions. Score 1 point for each answer selected which indicates depression. Score of 0-5 is normal. A score &gt;5 suggests depression.</description>
        <time_frame>Preoperatively, post operative day 1 and post op day3</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caldolor/Ibuprofen</title>
            <description>800mg administered IV in 100mL normal saline over 5 minutes prior to surgical incision.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.</description>
          </group>
        </group_list>
        <measure>
          <title>Geriatric Depression Scale</title>
          <description>15 questions. Score 1 point for each answer selected which indicates depression. Score of 0-5 is normal. A score &gt;5 suggests depression.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>preoperative score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="1.1"/>
                    <measurement group_id="O2" value="0.7" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="0.9"/>
                    <measurement group_id="O2" value="0.9" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day #1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="1.1"/>
                    <measurement group_id="O2" value="0.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post op day #3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.8"/>
                    <measurement group_id="O2" value="0.12" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>-day of surgery to post operative day 3</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Caldolor/Ibuprofen</title>
          <description>800mg administered IV in 100mL normal saline over 5 minutes prior to surgical incision.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>SNOMED CT</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>patient unable to be extubated at the end of the surgical procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alex Bekker, MD, PhD</name_or_title>
      <organization>Rutgers/State University of New Jersey (NJMS)</organization>
      <phone>973 972-5007</phone>
      <email>bekkeray@njms.rutgers.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

